Literature DB >> 6106902

Reduction of dopaminergic supersensitivity by a single dose of amphetamine.

J L Haracz, L F Tseng.   

Abstract

Chronic administration of haloperidol in rats resulted in a supersensitivity to apomorphine-induced stereotypy. This behavioral supersensitivity was reduced by a single administration of d-amphetamine given 2 days after the termination of haloperidol injections. The reduction of haloperidol-induced supersensitivity by amphetamine lasted for at least 3 days after amphetamine injection.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6106902     DOI： 10.1007/bf00498568

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


  11 in total

1.  Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.

Authors:  M Gnegy; P Uzunov; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1977-09       Impact factor: 4.030

2.  Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.

Authors:  R C Smith; J M Davis
Journal:  Life Sci       Date:  1976-09-01       Impact factor: 5.037

Review 3.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

4.  Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.

Authors:  M Quik; L L Iversen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

5.  Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.

Authors:  G Gianutsos; R B Drawbaugh; M D Hynes; H Lal
Journal:  Life Sci       Date:  1974-03-01       Impact factor: 5.037

6.  Stereotypic and anticataleptic activities of amphetamine after intracerebral injections.

Authors:  B Costall; R J Naylor; J E Olley
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

7.  Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.

Authors:  S J List; P Seeman
Journal:  Life Sci       Date:  1979-04-16       Impact factor: 5.037

8.  Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.

Authors:  A V Christensen; I M Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

9.  Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs.

Authors:  C A WINTER; L FLATAKER
Journal:  J Pharmacol Exp Ther       Date:  1950-03       Impact factor: 4.030

10.  Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

Authors:  A J Friedhoff; K Bonnet; H Tosengarten
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-03
View more
  2 in total

1.  Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?

Authors:  V J Nickolson; H van Riezen; A M van Delft
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.

Authors:  L R Troncone; T M Ferreira; S Braz; N G Silveira Filho; S Tufik
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.